Autoimmune Disease Diagnostics Market Trends

Autoimmune Disease Diagnostics Market Trends

The substantial surge in the number of patients affected by autoimmune diseases is among the major factors propelling market growth in the foreseeable future. Type 1 diabetes, rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease are some of the most common conditions that require autoimmune diagnostics and treatment.
 

• Type 1 diabetes is a chronic ailment generally caused when the immune system attacks and destroys insulin-producing cells in the pancreas. This results in high blood sugar levels, which, if left untreated, may lead to multiple organ failures, including the heart, kidneys, nerves, and more.
   
• For instance, according to reports published by the International Diabetes Federation in 2021, over 1.2 million children and adolescents under the age of 19 are affected by Type 1 diabetes, and the numbers are steadily increasing. Moreover, according to the American Diabetes Association, in 2019, over 1.9 million Americans were suffering from Type 1 diabetes. The increasing prevalence of such diseases leads to significant health consequences and comorbidities, resulting in substantial mortality.
   
• As a result, with the surging patient population, the market is anticipated to see a significant rise in the adoption of autoimmune disease diagnostics soon.